Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Mike Lenardo speaks about early links between the NIH (National Institute of Health, USA) and the University of Oxford, and their success in setting up the NIH-Oxford-Cambridge DPhil programme.

Professor Lenardo also talks about his work investigating immunological regulation and disorders using a human genetic approach.

Professor Mike Lenardo

T cell regulation

mikeProfessor Michael J. Lenardo is Section Chief for the Molecular Development of the Immune System Section, at the National Institutes of Health, USA. Professor Lenardo’s laboratory investigates the molecular regulation of T lymphocytes, particularly in relation to immunological tolerance, apoptosis, and autoimmune diseases. His goal is to understand the pathogenesis of autoimmunity from the vantage point of T-cell regulation, as well as to develop novel means of diagnosis and immunomodulation for these diseases. Professor Lenardo is also investigating how HIV causes the death of CD4 T lymphocytes. The aim of this research is to eventually develop new treatments, or vaccines, for AIDS.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.